Avalide 300/12.5
Avalide 300/12.5 is a topic covered in the Davis's Drug Guide.
To view the entire topic, please sign in or purchase a subscription.
Davis’s Drug Guide App + Web powered by Unbound Medicine provides up-to-date information on 5000+ trade name and generic drugs. View on the web or download App to your iPhone, iPad, or Android smartphone or tablet. Davis Drug Guide PDF. Explore these free sample topics:
Citation
Quiring, Courtney, et al. "Avalide 300/12.5." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. www.drugguide.com/ddo/view/Davis-Drug-Guide/61038/all/Avalide_300_12_5.
Quiring C, Sanoski CA, Vallerand AH. Avalide 300/12.5. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61038/all/Avalide_300_12_5. Accessed June 27, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Avalide 300/12.5. In Davis's Drug Guide. Available from https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61038/all/Avalide_300_12_5
Quiring C, Sanoski CA, Vallerand AH. Avalide 300/12.5 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 June 27]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61038/all/Avalide_300_12_5.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Avalide 300/12.5
ID - 61038
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61038/all/Avalide_300_12_5
PB - F.A. Davis Company
ET - 16
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -